Volume | 458,802 |
|
|||||
News | - | ||||||
Day High | 6.45 | Low High |
|||||
Day Low | 5.51 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Palisade Bio Inc | PALI | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
5.69 | 5.51 | 6.45 | 6.35 | 5.92 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
3,369 | 458,802 | $ 5.93 | $ 2,721,073 | - | 3.82 - 36.60 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:59:53 | 50 | $ 6.25 | USD |
Palisade Bio Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
18.44M | 12.13M | - | 250k | -12.3M | -1.01 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Palisade Bio News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PALI Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 6.23 | 8.17 | 4.50 | 5.94 | 5,083,675 | 0.02 | 0.32% |
1 Month | 5.70 | 8.84 | 3.82 | 5.92 | 2,641,556 | 0.55 | 9.65% |
3 Months | 8.85 | 9.375 | 3.82 | 6.14 | 1,074,822 | -2.60 | -29.38% |
6 Months | 9.00 | 22.35 | 3.82 | 11.47 | 1,785,692 | -2.75 | -30.56% |
1 Year | 26.10 | 36.60 | 3.82 | 15.91 | 1,742,275 | -19.85 | -76.05% |
3 Years | 6,750.00 | 8,182.50 | 3.82 | 349.29 | 2,031,176 | -6,743.75 | -99.91% |
5 Years | 6,750.00 | 8,182.50 | 3.82 | 349.29 | 2,031,176 | -6,743.75 | -99.91% |
Palisade Bio Description
Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery. |